Darren Mougey

Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
  • Analysts warn of multiple risky stocks amid industry headwinds, with caution toward firms relying on volatile assets and outdated models.
  • Rapidly growing Canyon Fire near Lake Piru forces evacuations as firefighters battle the blaze.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Gilead Sciences reports strong Q2 2025 results, driven by robust HIV drug sales, and raises full-year guidance, making its stock a top performer.
  • Analysts warn of multiple risky stocks amid industry headwinds, with caution toward firms relying on volatile assets and outdated models.
  • Rapidly growing Canyon Fire near Lake Piru forces evacuations as firefighters battle the blaze.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Darren Mougey